| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;51:884.)
© 2008 American Heart Association, Inc.
Original Articles |
From the Department of Physiology and Biophysics (A.A.d.S., J.M.d.C., J.D., E.B., J.E.H.), the Department of Anatomy (B.K.), and the Center for Excellence in Cardiovascular-Renal Research (A.A.d.S., J.M.d.C., J.D., E.B., J.E.H.), University of Mississippi Medical Center, Jackson.
Correspondence to Alexandre A. da Silva, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505. E-mail asilva{at}physiology.umsmed.edu
Previous studies suggest that activation of the CNS melanocortin system reduces appetite while increasing sympathetic activity and arterial pressure. The present study tested whether endogenous activity of the CNS melanocortin 3/4 receptors (MC3/4-R) contributes to elevated arterial pressure in the spontaneously hypertensive rat (SHR), a model of hypertension with increased sympathetic activity. A cannula was placed in the lateral ventricle of male SHR and Wistar (WKY) rats for chronic intracerebroventricular (ICV) infusions (0.5 µL/h). Mean arterial pressure (MAP) and heart rate (HR) were recorded 24 hour/d using telemetry. After 5-day control period, rats were infused with MC3/4-R antagonist (SHU-9119, 1 nmol/h-ICV) for 12 days, followed by 5-day posttreatment period. MC3/4-R antagonism increased food intake in SHR by 90% and in WKY by 125%, resulting in marked weight gain, insulin resistance, and hyperleptinemia in SHR and WKY. Despite weight gain, MC3/4-R antagonism reduced HR in SHR and WKY (
40 bpm), while lowering MAP to a greater extent in SHR (–22±4 mm Hg) than WKY (–4±3 mm Hg). SHU9119 treatment failed to cause further reductions in MAP during chronic adrenergic blockade with propranolol and terazosin. These results suggest that endogenous activity of the CNS melanocortin system contributes to the maintenance of adrenergic tone and elevated arterial pressure in SHR even though mRNA levels for POMC and MC4R in the mediobasal hypothalamus were not increased compared to WKY. These results also support the hypothesis that weight gain does not raise arterial pressure in the absence of a functional MC3/4-R.
Key Words: leptin melanocortin hypertension food intake blood pressure POMC insulin
This article has been cited by other articles:
![]() |
G. L. C. Yosten and W. K. Samson Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R330 - R336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Landa, S. I. Garcia, M. L. Schuman, A. L. Alvarez, S. Finkielman, and C. J. Pirola Thyrotropin-Releasing Hormone Precursor Gene Knocking Down Impedes Melanocortin-Induced Hypertension in Rats Hypertension, August 1, 2008; 52(2): e8 - e8. [Full Text] [PDF] |
||||
![]() |
A. A. da Silva, J. M. do Carmo, B. Kanyicska, J. Dubinion, E. Brandon, and J. E. Hall Response to Thyrotropin-Releasing Hormone Precursor Gene Knocking Down Impedes Melanocortin-Induced Hypertension in Rats Hypertension, August 1, 2008; 52(2): e9 - e9. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |